2-(MORPHOLIN-4-YL)-L,7-NAPHTHYRIDINES

The present invention relates to substituted 2-(morpholin-4-yl)-l,7-naphthyridine compounds of general formula (I) or (lb), to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds...

Full description

Saved in:
Bibliographic Details
Main Authors Ulrich LÜCKING, Gerhard SIEMEISTER, Hans SCHICK, Dieter MOOSMAYER, Lars WORTMANN, Wilhelm BONE, Franz VON NUSSBAUM, Julien LEFRANC, Philip LIENAU, Joanna GRUDZINSKA-GOEBEL, Knut EIS, Marcus KOPPITZ, Antje Margret WENGNER, Hans BRIEM, Benjamin BADER, Uwe EBERSPÄCHER
Format Patent
LanguageEnglish
Spanish
Published 27.04.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to substituted 2-(morpholin-4-yl)-l,7-naphthyridine compounds of general formula (I) or (lb), to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyperproliferative disease as a sole agent or in combination with other active ingredients. Compuestos 2-(morfolin-4-iI)-1,7-naftiridina sustituidos de la fórmula general (I) o (Ib), (ver Fórmulas) métodos de preparación de dichos compuestos, compuestos intermediarios de utilidad para preparar dichos compuestos, composiciones farmacéuticas y combinaciones que comprenden dichos compuestos y el uso de dichos compuestos en la elaboración de una composición farmacéutica para el tratamiento o la profilaxis de una enfermedad, en particular de una enfermedad hiperproliferativa como único agente o en combinación con otros ingredientes activos.
Bibliography:Application Number: MX20170001637